InvestorsHub Logo
Followers 30
Posts 2204
Boards Moderated 0
Alias Born 01/09/2017

Re: Idunno post# 12434

Sunday, 07/15/2018 4:04:21 AM

Sunday, July 15, 2018 4:04:21 AM

Post# of 27424
The below copy n paste is why I believe CTSO seemingly opened up the possibility of selling the tree. I could be wrong. I see the words “strategic partnership” as well. But I’m posting as this is what grabbed my attention.
So,
The below excerpt is taken from the 12 March 2018 Cowen 38th annual health care conference. It was part of a Q and A session, after Dr. Chan’s presentation to Cowen, and their analyst, Josh Jennings. ...

COPY n PASTE;
<Q>: [Question Inaudible]
<A – Phillip P. Chan>: Well I think that one, if we were a standalone company we believe that we could be a very highly profitable business, again a very cash flow rich business based on our highly profitable razorblade and someone else's razor business model. We believe that that will be very well valued in the marketplace, because it is a very unique position to be in. Again a lot of medical device companies that you'll see have high growth, but also lose more than what they sell. We are not that way, we believe that we will actually be able to show the underlying profitability.
So that opens up a wide variety of different options for us either to stay independent, have the stock market value us the way that it will, but it also potentially opens up the potential M&A in
the future either via strategic partner or by a private equity group that likes the cash flow business, right. So I think it's kind of a potentially nice position to be in, particularly if we can continue to execute. Yes.
<Q>: [Question Inaudible]
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CTSO News